Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Editorial board
The Publisher
Abstracting and indexing
Publication ethics
Privacy Statement
Contact
Policies
Open access policy
Editorial policies
Authors' self archiving and sharing policy
Commercial policies
Privacy policy
Guidelines
Guidelines for authors
Guidelines for Reviewers
Artwork guidelines
Publication fees
Archives
Current
Search
Register
Login
Submit now
Home
/
Archives
/
Vol. 3 No. 3 (2016): September-December 2016
Vol. 3 No. 3 (2016): September-December 2016
Published:
2016-12-31
Point of View
Improving the Management of High Cost Anticancer Drugs in a Health Care System
Alberto Russi, Vera Damuzzo, Marta Serena, Frida Gorreja, Angelo C. Palozzo
155-158
PDF
Clinical and Economic Management of Uterine Fibroids: The Point of View of a Decision Makers Board
La gestione clinica ed economica del fibroma uterino: il punto di vista di un Decision Makers Board
Costantino Di Carlo, Antonio Maiorana, Ignazia Poidomani, Roberto Ravasio, Adriano Vercellone
159-164
PDF
Difficulties and Challenges in the Management of Market Access for Innovative Oncological Therapies
La complessità e le sfide dell'accesso al mercato delle terapie innovative in oncologia
Alberto Zaniboni, Roberto Ravasio
165-168
PDF
Original Research Articles
Prevalence, Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis
L'impatto della manovra AIFA sui costi di trattamento con ICS-LABA: focus sui pazienti affetti da asma e BPCO
Alessandra Bettiol, Jenny Bolcato, Roberta Pirolo, Giulia Franchin, Paola Deambrosis, Pietro Giusti, Alessandro Chinellato
115-124
PDF
Observational Analysis of Antineoplastic and Immunomodulating Drug Expenditure in Two Local Health Units in Northern Italy during the Period 2009-2011
Analisi osservazionale della spesa per farmaci antineoplastici e immunomodulatori a carico di due ASL del Nord Italia durante il triennio 2009-2011
Carlo Cerra, Mirosa Dellagiovanna, Simona Migliazza, Roberto Tettamanti, Corrado Zuliani, Roberto Ravasio, Delia Colombo, Claudia Pitotti, Emanuela Zagni
134-143
PDF
Economical Evaluation of the Sustain Program for the Out-of-Hospital Administration of Abatacept for Rheumatoid Arthritis
Valutazione economica del programma SuSTAin per la somministrazione territoriale di abatacept nel trattamento dell'artrite reumatoide
Maurizio Muratore, Alberto Migliore, Francesca d’Onofrio, Roberto Perricone, Romano Bucci, Crescenzio Scioscia, Angelica Gattamelata, Felice Sensi, Giovanni Minisola, Marina Lo Vullo, Maria Iolanda Famà, Roberto Ravasio
144-149
PDF
Cost-Effectiveness Analysis of Triptorelin versus Leuprolide in the Treatment of Advanced Prostate Cancer
Analisi di costo efficacia di triptorelina rispetto a leuprorelina nel trattamento del tumore alla prostata in stadio avanzato
Roberto Ravasio
150-154
PDF
Evolution of the Healthcare Expenditure in Italy and Effects of Fingolimod Increased Prescribing in Second Line Treatment of Relapsing-Remitting Multiple Sclerosis
Evoluzione della spesa sanitaria in Italia ed effetti della prescrizione di fingolimod in seconda linea nella sclerosi multipla recidivante-remittente
Matteo Ruggeri, Andrea Aiello, Anna D’Ausilio, Eugenio Di Brino, Salvatore Cottone, Angelo Ghezzi, Lorella Lombardozzi, Alessandra Mecozzi, Dario Sacchini, Alessandro Roccia, Monica Mangone, Mondher Toumi
125-133
PDF
Sign up
Browse
Categories
Health Technology Assessment
Health Policies
banners150
Completed peer reviews since:
November 4, 2020